| Term 
 
        | What is the origin of ADHF? |  | Definition 
 
        | - Noncompliance with medication - Salt/Fluid overload
 - Uncontrolled HTN or Afib
 - Inappropriate meds: NSAIDS, non-DHP CCBs, Actos, Metformin
 - Cardiac event, endocrine diseases
 |  | 
        |  | 
        
        | Term 
 
        | How are ADHF patients assessed? |  | Definition 
 
        | - Fluid status - Wet or Dry - Orthopnea, Ascites, JVD, pitting edema, Rales - Perfusion status - Cold or Warm - low BP and cool extremities
 - Onset $ Factors
 |  | 
        |  | 
        
        | Term 
 
        | What is a HF patient considered to be decompensated? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What lab values lead to a diagnosis and assessment of HF? |  | Definition 
 
        | - B-type Natriuretic Peptide over 100, will be very high - Swan-Ganz Catheter measures PCWP, an indicator of fluid status. 15-18 is normal, above 18 is congested
 - Cardiac index measures perfusion, Above 2.2 is normal, below 2.2 is hypoperfused.
 - Perform invasive monitoring in patients w/ respiratory distress or persistent symptoms
 |  | 
        |  | 
        
        | Term 
 
        | What is Quadrant 1 in the hemodynamics chart? |  | Definition 
 
        | Quadrant I - Warm and Dry/best outcome: PCWP is below 18 and CI is Above 2.2. No congestion or hypoperfusion |  | 
        |  | 
        
        | Term 
 
        | What is Quadrant 2 in the hemodynamics chart? |  | Definition 
 
        | Quadrant 2 - Warm and wet - CI is above 2.2 but PCWP is over 18, indicating fluid overload |  | 
        |  | 
        
        | Term 
 
        | What is Quadrant 3 in the hemodynamics chart? |  | Definition 
 
        | Quadrant 3 - Cold and dry: CI is below 2.2 while PCWP is below 18, indicating hypoperfusion. |  | 
        |  | 
        
        | Term 
 
        | What is Quadrant 4 in the hemodynamics chart? |  | Definition 
 
        | Quadrant 4 - Cold and wet/worst outcome: CI is below 2.2 and PCWP is above 18, indicating hypoperfusion and fluid overload |  | 
        |  | 
        
        | Term 
 
        | How is Quadrant 1 (Warm and dry) treated? |  | Definition 
 
        | Optimize their oral therapies to target dose ranges for CHF, make sure they are on Lasix, an AceI, and a BB. |  | 
        |  | 
        
        | Term 
 
        | How do you treat Quadrant 2 (Warm and Wet)? |  | Definition 
 
        | Maintain cardiac output with oxygen Restrict fluid and salt
 use IV preload reducers:
 Loop diuretics (first) --> Vasodilators (second) - NTG/Nitroprusside/Nesitiride
 - Continuous infusion of Lasix, may add 2nd diuretic (Metolazone), may add vasodilator if no hypotension exists
 |  | 
        |  | 
        
        | Term 
 
        | How is Quadrant 3 (Cold and dry) treated? |  | Definition 
 
        | - Maintain fluid status at 15-18, may give IV fluids - Give IV positive inotropes (Dobutamine, milrinone) or possibly vasodilators to increase CO
 |  | 
        |  | 
        
        | Term 
 
        | How is Quadrant 4 (Cold and Wet) treated? |  | Definition 
 
        | - Give positive inotropes to increase CO/CI FIRST, if this does not work, give vasodilators, then diuretics. - Give Diuretics and vasodilators to decrease PCWP and fluid overload
 - Careful monitoring, most severe state
 |  | 
        |  | 
        
        | Term 
 
        | How do diuretics work and how are they dosed? |  | Definition 
 
        | - Reduce preload by promoting Na/H2O excretion - Identify total home dose, give that dose as a bolus (max 180 mg). If not on home dose, give 40 mg IVP if SCr <2 and 80 mg IVP if SCr > 2
 - Check urine output at 2 hours, goal is 500 mL (250 mL if SCr >2.5). If not at goal output, DOUBLE initial bolus
 |  | 
        |  | 
        
        | Term 
 
        | How can diuretic resistance be overcome? |  | Definition 
 
        | - Higher bolus and continuous infusion of Lasix - Addition of Metolazone, Chlorthiazide, or Spironolactone
 - Last line: Ultrafiltration
 |  | 
        |  | 
        
        | Term 
 
        | When should vasodilators NOT be used? |  | Definition 
 
        | When systolic blood pressure is less than 90. |  | 
        |  | 
        
        | Term 
 
        | What drugs are vasodilators and how do they work? |  | Definition 
 
        | Reduce preload and afterload - Nitroprusside - use in patients with very high SVR, watch cyanide toxicity
 - Nitroglycerine - milder vasodilator, can develop tolerance
 - Nesiritide - Venodilator, coming off formulary
 - may be ADDED to wet patients where diuretics are not working
 |  | 
        |  | 
        
        | Term 
 
        | What drugs are positive inotropes and how do they work? |  | Definition 
 
        | - increase cAMP levels, either beta agonists or PDE-3 inhibitors - Dobutamine - beta-agonist, helps in hypoperfusion and hypotension, DOES NOT WORK with beta-blockers --> use milrinone
 - Milrinone - PDE-3 inhibitor, more significant side effects. Do not use in low BP, use Dobutamine
 - Dopamine - Beta agonist, use only in drastic hypotension/shock
 |  | 
        |  | 
        
        | Term 
 
        | How should CHF medications be handled while in ADHF? |  | Definition 
 
        | - Continue AceI therapy in the absence of contraindications - Resume beta blocked ONLY when stable, fluid status and BP optimized
 |  | 
        |  | 
        
        | Term 
 
        | In summary, how do you treat each quadrant of ADHF? |  | Definition 
 
        | I – Warm and Dry – AceI/ARB, BB, Loop II – Warm and Wet – Loop Diuretics and Vasodilators, no inotropes
 III – Cold and Dry – Inotropes, fluids to get to goal. + or – vasodilators depending on SBP and PCWP
 IV – Cold and Wet – Loop diuretics, Inotropes, Vasodilators
 |  | 
        |  |